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Abstract
Purpose We comparatively evaluated urethral stric-
ture (US) treatment outcomes, efﬁcacy and complica-
tions, using either holmium laser endourethrotomy
(HLU) or optical internal urethrotomy (OIU) since
studies such as this are scarce in literature.
Methods During 2003–2008, 50 men aged 17–
78 years were operated on for primary or refractory
US, 32 (64%) and 18 (36%) patients, respectively. The
average stricture length was 1.86 cm. Strictures were
single or multiple, forty-one (82%) and nine (18%)
patients,respectively,andwerelocatedintheanterioror
posterior urethra in 27 (54%) and 32 (64%) patients,
respectively. US were iatrogenic in 32 (64%) and
idiopathic in 18 (36%). Patients were divided into two
groups,grpAandgrpB,eachcontaining25patientswho
weretreatedusingeitherHLUorOIU,respectively.An
evaluationscaleof1–3wasadoptedandtookmaximum
ﬂowrate(Qmax),postvoidresidual(PVR),andqualityof
life (QL) into consideration. A score of ‘1 was very
good,‘ 2w a sgood, and ‘3 was poor.
Results Treatment results were evaluated after 3, 6,
and 12 months, respectively. Evaluation of grpA was
as follows: ﬁve (20%), nine (36%), and seven (28%)
patients scored a ‘1; thirteen (52%), nine (20%), and
four (16%) patients scored a ‘2; and seven (28%),
eleven (44%), and fourteen (56%) patients scored a ‘3.
Evaluation of grpB: seven (28%), ten (40%), and ﬁve
(20%) patients scored a ‘1; eleven (44%), seven
(28%), and ten (40%) patients scored a ‘2; and seven
(28%),eight(32%),andten(40%)patientsscoreda‘3.
Conclusions Neither complication rate nor degree of
efﬁcacy between HLU and OIU for US revealed a
signiﬁcant difference. We found both laser and
conventional urethrotomies to be safe and effective
modes of treatment.
Keywords Conventional urethrotomy  Endoscopic
urethrotomy  Holmium laser endourethrotomy 
Optical internal urethrotomy  Urethral stricture
Introduction
Since 1974, Sachse’s optical internal urethrotomy
(OIU) has been considered the treatment of choice for
urethral stricture (US); however, the occurrence of
refractory strictures has made results unsatisfactory
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several alternatives have been evaluated and include
the holmium laser, which was introduced into urolog-
ical practice in the early ‘90 s and uses a pulsed
monochrome light (k = 2100 nm) while allowing
energy transfer through a 200–1000 lm ﬁber [3–5].
This study aimed to evaluate the outcomes of the
laser and conventional urethrotomies that were per-
formed atE. MichalowskiMemorial UrologyHospital
in Katowice, Poland.
Patients and methods
This prospective study included 50 men aged
17–78 years (mean = 63.45) with primary or refrac-
tory US who were operated on during 2003–2008 at E.
Michalowski Memorial Urology Hospital in Katow-
ice, Poland. The diagnosis of US was based on
international prostate symptom scores (IPSS), quality
of life (QL), clinical history, uroﬂowmetry (UF),
ultrasonography (USG), and urethrography.
The etiology of US was primary in 32 (64%) and
refractory in 18 (36%) patients. Stricture length did
not exceed 3 cm, and single stricture occurred in 41
(82%) patients while multiple strictures occurred in
nine (18%). US of the anterior urethra were present in
27 (54%) and posterior urethra in 32 (64%) patients.
All patients with refractory US were previously
treated with OIU. The etiology of US was iatrogenic
in 32 (64%) and idiopathic in 18 (36%). Iatrogenic
causes were attributed to transurethral resection of
prostate (TURP), transurethral resection of bladder
tumor (TURBt), lower urinary tract stent, radiother-
apy, and radical prostatectomy in seventeen (34%),
one (2%), one (2%), ﬁve (10%), one (2%), and seven
(14%) patients, respectively.
Thepredominantsymptomwasaweakurinestream,
which occurred in 45 (90%) patients. Other symptoms
included refractory lower urinary tract infection, urine
stream deviation, interrupted urine stream, painful
micturition, urinary retention, difﬁculty initiating uri-
nation, and paradoxical urinary incontinence in seven
(14%), eight (16%), seven (14%), ten (20%), nine
(18%), thirteen (26%), and one (2%) patient,
respectively.
After clinical evaluation, patients were numbered
and assigned to grpA or grpB (odd or even numbered
patients, respectively) and were treated with HLU and
OIU, respectively. Laboratory tests, USG, postvoid
residual (PVR), and UF (Qmax and Qave) were
determined pre- and postoperatively, together with
IPSS and QL. Patients were evaluated at 3, 6, and
12 monthspostoperatively.Anevaluationscaleof1–3
was adopted: a score of ‘1 was very good:Q max
[15 ml/s, PVR\50-ml, QL 0–1 points; ‘2 was good:
Qmax 8–14 ml/s, PVR 50–100 ml, QL 2–3 points; and
‘3 was poor:Q max \8 ml/s, PVR [100 ml, QL 4–5
points.
Surgical technique of urethrotomy
The lithotomy position was used for all operations
with subarachnoid anesthesia and perioperative cip-
roﬂoxacin prophylaxis (2 9 500 mg).
For HLU, The holmium laser (Coherent Inc.) used
boasted 100 W of power and a 365-nm laser ﬁber. To
begin, an optical urethrotome or a 21F Storz cysto-
scope was inserted into the urethra along with a guide
wire, both of which were followed by a urethrotome
that was guided to the area of stricture. The 365-nm
ﬁber of the laser was then inserted, and the cutting of
thescarwasinitiatedmostcommonlyatthe12-o’clock
position. The laser energy used was 0.8–1.5 J (mean,
1.2 J) with a frequency of 8–15 Hz (mean, 12 Hz) and
power of 6.4–22.5 W (mean, 14 W).
During OIU, a 21 Charr optical urethrotome was
inserted into the urethra, and the US repair was
initiatedinthe conventional way. Lastly, urethroscopy
was performed, an 18F Foley catheter was placed, and
patients were released.
Statistics
Values for the following descriptive parameters
were calculated: average values, standard deviations,
calculated minimum and maximum values for measur-
able variables, and the percentages for non-measurable
variables(qualitative).TheShapiro–Wilk,Mann–Whit-
ney U, and Friedman’s tests were used and analysis of
resultswasdividedintotwostages.Theﬁrstentailedthe
calculation of fractions (percentages) with respect to
quality characteristics: types and location of US,
etiology, symptoms, as well as the results of IPSS and
QL. During the second stage, the following values for
basic descriptive parameters of measurable variables
were analyzed: age of patient, length of US, Qmax,a n d
PVR.
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We began by assessing the differences in type, size,
and location of US between the studied groups and
found no statistically signiﬁcant differences (Fig. 1).
Then, we analyzed the prevalence of the typical
symptoms associated with US in both of the studied
groups and also found no statistically signiﬁcant
differences between the groups.
Before treatment, IPSS was assessed and the
average score for both groups was 21.2 points. After
treatment, however, grpA obtained 21.6 points while
grpB obtained 20.8, but no statistically signiﬁcant
difference was found between the groups (P[0.05).
IPSSwas alsoassessed duringthe 12-monthfollow-up
and showed improvement, but revealed no statistically
signiﬁcant difference between the groups (P[0.05)
with average scores of 17.2 and 17.4 points for grpA
and grpB, respectively.
We also assessed QL before and after treatment as
well as during 12-month follow-up. Before treatment,
grpA and grpB scored an average 4.6 points. After
treatment, patients scored 4.7 and 4.5 points, respec-
tively, with no statistically signiﬁcant difference
between the groups (P[0.05). During 12-month
follow-up,theyscored2.6and2.8points,respectively,
with no statistically signiﬁcant difference between the
groups (P[0.05).
Values for basic descriptive parameters (age, length
of stricture, UF, and PVR) were calculated for both
groups, grpA and grpB, and can be found in Tables 1
and 2, respectively. Evaluation of the data revealed
that the majority of characteristics (especially PVR)
deviated from the normal distribution. Analysis of
patient age and length of US revealed no statistically
signiﬁcant differences between the groups (P[0.05).
Figure 2 presents the results of UF (Qmax), which did
not reveal any statistically signiﬁcant differences
between the studied groups irrespective of the
observation stage (P[0.05). Values of PVR before
surgery were signiﬁcantly higher in grpA than in
grpB; however, the remaining observation stages did
not show any statistically signiﬁcant differences
(P[0.05) (Fig. 3).
Evaluation for the signiﬁcance of changes in the
measurable characteristics in each of the studied
groups revealed a deviation from the normal distribu-
tion, and therefore, further statistical analysis was
performed using Friedman’s test. Figures 4, 5 present
the results for grpA and Figs. 6, 7 for grpB.
Very high Qmax value changes were observed in
grpA (Fig. 4): after 3 months a strong increase
(P = 0.0002) and after 6 months an insigniﬁcant
decrease (P[0.05) were observed in relation to
baseline, but still signiﬁcantly higher than before
surgery (P = 0.002). After 12 months, a further
insigniﬁcant decrease occurred (P[0.05) reaching
a level higher than baseline, but without statistical
signiﬁcance (P[0.05).
Resemble was the results for statistical evaluation
of changes in Qave. The decline seen from the third to
twelfth months after surgery was statistically signif-
icant. Qave almost returned to preoperative baseline.
Figure 5 shows the signiﬁcance of changes in
PVR in grpA. The very high baseline PVR expe-
rienced a sharp decline 3 months after surgery
Fig. 1 Types and
localizations of urethral
strictures in studied groups
A and B—results of tests
from both groups
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3 months (insigniﬁcant, P[0.05), reaching a level
markedly lower than baseline (P\0.0001). How-
ever, in the last period, a statistically insigniﬁcant
increase appeared (P[0.05). Ultimately, the PVR
approached baseline, although still lower, showing
statistical signiﬁcance (P = 0.0014).
Qmax for grpB revealed similar changes as in grpA,
both as to character and signiﬁcance (Fig. 6). The
nature of changes in Qave in grpB is similar to that in
grpA.
Shown inFig. 7are changesinthe nature ofPVRin
grpB that are similar to those found in grpA. After
3 months, there was a decline in PVR, which grew
slowly at ﬁrst then slightly faster later. The ﬁnal PVR
ofgrpBwasclosertothebaselinethanthatobservedin
grpA. PVR after 1 year of observation was slightly
lower (no signiﬁcance) compared to baseline.
Table 1 Descriptive parameters and veriﬁcation of ‘normal’ distribution of analyzed measureable characteristics in the studied
patients of group A (laser)
Group Characteristics Observation stage
(months)
Mean SD Min Max Shapiro–Wilk test
Laser (group A) Age (years) Before operation 61.2 16.1 17.0 79.0 <0.05
Length of stricture (cm) Before operation 1.86 1.26 0.50 3.00 <0.05
Qmax—maximum ﬂow (ml/s) Before operation 4.96 3.13 0.00 13.00 [0.05
3 11.44 8.14 0.00 37.00 <0.05
6 10.72 8.43 0.00 34.00 [0.05
12 10.60 10.04 0.00 36.00 <0.05
Qave—average ﬂow (ml/s) Before operation 2.96 1.72 0.00 6.00 [0.05
3 6.68 4.04 0.00 14.00 [0.05
6 6.52 4.99 0.00 20.00 [0.05
12 5.28 4.61 0.00 17.00 <0.05
PVR retention (ml) Before operation 87.6 38.8 0.00 154.0 [0.05
3 35.05 33.89 0.00 150.00 <0.05
6 40.64 41.60 0.00 200.00 <0.05
12 37.48 40.99 0.00 170.00 <0.05
Table 2 Descriptive
parameters and veriﬁcation
of ‘normal’ distribution of
analyzed measureable
characteristics in the studied
patients of group B
(classical urethrotomy)
Classical urethrotomy (group B)
Age (years) Before operation 65.7 11.9 37.0 87.0 [0.05
Length of stricture (cm) Before operation 1.66 1.02 0.50 3.00 <0.05
Qmax—maximum ﬂow (ml/s) Before operation 5.80 4.09 0.00 14.00 [0.05
3 11.92 6.84 0.00 29.00 [0.05
6 11.80 9.35 0.00 39.00 [0.05
12 9.80 7.85 0.00 34.00 <0.05
Qave—average ﬂow (ml/s) Before operation 3.24 2.03 0.00 7.00 [0.05
3 6.52 3.56 0.00 14.00 [0.05
6 6.80 4.84 0.00 20.00 [0.05
12 5.44 3.76 0.00 15.00 <0.05
PVR Retention (ml) Before operation 70.6 43.2 0.00 198.0 <0.05
3 47.54 52.55 0.00 268.00 <0.05
6 52.32 56.17 0.00 268.00 <0.05
12 48.40 34.93 0.00 115.00 [0.05
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123Fig. 2 Values of maximum urine ﬂow Qmax in both groups
during consecutive observation stages—results of the Mann–
Whitney test
Fig. 3 Urine retention (R) in both groups during consecutive
observation stages—results of the Mann–Whitney test
Fig. 4 Evaluationofsigniﬁcanceofchangesinmaximumurine
ﬂow rate (Qmax) during consecutive observation stages in group
A—results of Friedman test
Fig. 5 Evaluation of signiﬁcance of changes in urine retention
(PVR) during consecutive observation stages in group A—
results of Friedman test
Fig. 6 Evaluationofsigniﬁcanceofchangesinmaximumurine
ﬂow rate (Qmax) during consecutive observation stages in group
B—results of Friedman test
Fig. 7 Evaluation of signiﬁcance of changes in urine retention
(R) during consecutive observation stages in group B—results
of Friedman test
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postoperative complications, nor clinically signiﬁcant
bleeding requiring blood transfusion.
As seen in Table 3, according to the adopted
criteria for evaluation of treatment results, it was
found that in grpA: a ‘1 was obtained by ﬁve (20%)
patients during 3-month follow-up, nine (36%) on
6-month, and seven (28%) by 12-month; a ‘2 was
obtained by thirteen (52%), ﬁve (20%), and four
(16%); and a ‘3 was obtained by seven (28%), eleven
(44%), and fourteen (56%), respectively. In grpB: a ‘1
was obtained by seven (28%), ten (40%), and ﬁve
(20%); a ‘2 by eleven (44%), seven (28%), and ten
(40%); and a ‘3 by seven (28%), eight (32%), and ten
(40%) patients, respectively.
Discussion
US in men are congenital or acquired pathologies
leading to narrowing of the urethral lumen, causing
subvesical obstruction. Untreated, they lead to irre-
versible changes in the upper and lower urinary tract.
Being characterized by a high recurrence, US require
patients to undergo numerous operations that expose
them to additional complications. The last ‘‘gold
standard’’ endoscopic urethrotomy was Sachse’s, but
restricture occurs in 89% of patients with efﬁcacy of
35–60% according to EAU Guidelines (2008) [1, 2].
Poor results were observed in 56% of our grpA after
1 year. Most of the restrictures appeared within the
ﬁrst 12 months, even in patients after second urethrot-
omy [6].
Since 1984, lasers have been used in urethrotomies:
Nd:YAG [7–14], argon [15, 16], diode [17], Ho:YAG
[18], and KTP [19]. The major advantages of laser
treatments include reduced blood loss and hospital
stay [20]. The Ho:YAG, or holmium, laser demon-
strates the shallowest absorption (\0.5 mm) with
smallest effect on surrounding tissues and is pre-
sumed to reduce scar tissue formation. Regardless,
data published until now have not demonstrated a
signiﬁcantly better outcome with Ho:YAG treatment
over other types of laser or cold-knife urethrotomy.
Perhaps, the postoperative development of restricture
not only depends on laser type, but also on many other
factors [21].
The results of treatment from grpA (Ho:YAG
laser 100 W) were compared with the results of
other authors [6, 22–26]. The etiology of Kamp’s
US patients [6] was similar to our patients. Kamp per-
formed all urethrotomy incisions at 6- or 12-o’clock,
or both, in the area of maximum cicatricial tissue
narrowing. There was no difference in the complica-
tion rate when an additional 6-o’clock incision was
made [6]. A similar procedure and laser parameters
were adopted for the treatment of our patients.
In the postoperative period, Kamp [6] maintained
an 18F catheter for 4 days and administered intraure-
thral triamcinolone to all patients after catheter
removal. Conversely, we maintained the catheter for
10 days without intraurethral steroid administration.
The duration of catheterization after endoscopic
incision of US remains under discussion with various
periods from 24 h to 6 weeks [21, 27, 28].
In 22(68.7%) of Kamp’s patients, second interven-
tion was unnecessary. Ten of his patients experienced
restricture; four (12.5%) of which were retreated with
Ho:YAG laser; and six (18.7%) underwent urethro-
plasty using buccal mucosa. Two patients underwent
second urethrotomy; however, 24 (75%) initial treat-
mentswereconsideredsuccessfulafter13–38 months.
Just as in Kamp’s patients [6], no intraoperative or
postoperative complications occurred.
The Ho:YAG laser offers a signiﬁcant advantage
with its coagulation ability. Rated as a safe and
minimally invasive therapeutic option comparable
with conventional urethrotomy, it can be at least an
alternative to urethroplasty when concurrent diseases
donotqualifypatients foropenurethralreconstruction
[6].
Hossain et al. [22] evaluated the results of treating
US up to 2 cm by using a Ho:YAG laser of similar
energy in men aged 15–60 years after 12 months. The
Table 3 Results of
treatment for urethral
stricture of group A (laser)
and group B (classical
urethrotomy) according to
adopted criteria
Treatment result 3 months 6 months 12 months
Group A B A B A B
Very good and good 18 (72%) 18 (72%) 14 (56%) 17 (68%) 11 (44%) 15 (60%)
Poor 7 (28%) 7 (28%) 11 (44%) 8 (32%) 14 (56%) 10 (40%)
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3 months, the following tests were conducted: UF,
urethrography, and voiding cystography. They found
that in 27 (90%) patients, Qave exceeded 16 ml/s and
the urethral caliber was appropriate. However, three
(10%) patients presented a narrower stream of urine
(Qave\8.0 ml/s) and urethrography conﬁrmed refrac-
tory US. In the assessment of our own patients, the
basic parameter of success was Qmax, not Qave, and
urethrography was not performed.
The literature regarding urethrotomy up till now has
not presented uniform criteria for evaluating the effec-
tivenessofUStreatment.Kamp’scriteria[6]waslackof
necessity for second intervention while Hossain et al.
[22] considered it to be failure to achieve appropriate
urine ﬂow (Qave\8 ml/s) as well as urethral restricture
in urethrography, but most of these refractory strictures
appeared within the ﬁrst 12 months [6].
In our goal to objectively analyze the results of
urethrotomy using the Ho:YAG laser, we randomly
created a similar group of patients who were treated
with classical urethrotomy (each group contained
25, without statistically signiﬁcant differences in
etiology of stricture, their number, localization,
length, or relevant symptoms). Assessment of treat-
ment effectiveness and complications were made on
the basis of UF in the third, sixth, and twelfth
months after treatment. The results obtained and
their evaluation on the basis of adopted criteria did
not conﬁrm a higher treatment effectiveness of the
holmium laser endourethrotomy (HLU) over the
classical optical internal urethrotomy (OIU) at
1-year follow-up.
Conclusion
Neither complication rate nor degree of efﬁcacy
between HLU and OIU for US revealed a signiﬁcant
difference. We found both laser and conventional
urethrotomies to be safe and effective modes of
treatment.
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